Protalix Biotherapeutics Inc (NYSE American:PLX)
| 3.54 Delayed Data As of Dec 01 |  -0.05 / -1.39%Today’s Change | 2.04 Today|||52-Week Range 4.87 | +7.93% Year-to-Date |
Latest PLX News | Press Releases
No recent news for Protalix Biotherapeutics Inc.
Today’s Trading
| Previous close | 3.59 |
| Today’s open | 3.54 |
| Day’s range | 3.51 - 3.57 |
| Volume | 53,744 |
| Average volume (3 months) | 120,105 |
| Market cap | $121.0M |
Data as of 3:59pm ET, 12/01/2020
Growth & Valuation
| Earnings growth (last year) | +31.50% |
| Earnings growth (this year) | +84.55% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +59.73% |
| P/E ratio | NM |
| Price/Sales | 0.89 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INMBINmune Bio Inc | -0.23 | -2.59% |
| EVGNEvogene Ltd | +0.02 | +0.58% |
| ELOXEloxx Pharmaceutical... | +0.09 | +3.15% |
| COGTCogent Biosciences I... | +0.73 | +7.44% |
Data as of 4:24pm ET, 12/01/2020
Financials
| Next reporting date | March 18, 2021 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $54.7M |
| Annual profit (last year) | -$18.3M |
| Net profit margin | -33.42% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Karmiel, Hazafon |
Forecasts
